284 related articles for article (PubMed ID: 2326474)
1. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Rabito CA; Bengele HH; Josephson L
Radiology; 1990 May; 175(2):489-93. PubMed ID: 2326474
[TBL] [Abstract][Full Text] [Related]
2. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
[TBL] [Abstract][Full Text] [Related]
3. MR receptor imaging: ultrasmall iron oxide particles targeted to asialoglycoprotein receptors.
Weissleder R; Reimer P; Lee AS; Wittenberg J; Brady TJ
AJR Am J Roentgenol; 1990 Dec; 155(6):1161-7. PubMed ID: 2122660
[TBL] [Abstract][Full Text] [Related]
4. Lymph nodes: microstructural anatomy at MR imaging.
Lee AS; Weissleder R; Brady TJ; Wittenberg J
Radiology; 1991 Feb; 178(2):519-22. PubMed ID: 1987619
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging.
Senéterre E; Weissleder R; Jaramillo D; Reimer P; Lee AS; Brady TJ; Wittenberg J
Radiology; 1991 May; 179(2):529-33. PubMed ID: 2014305
[TBL] [Abstract][Full Text] [Related]
6. Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents.
Reimer P; Kwong KK; Weisskoff R; Cohen MS; Brady TJ; Weissleder R
J Magn Reson Imaging; 1992; 2(2):177-81. PubMed ID: 1562768
[TBL] [Abstract][Full Text] [Related]
7. Long circulating superparamagnetic particles with high T2 relaxivity.
Pochon S; Hyacinthe R; Terrettaz J; Robert F; Schneider M; Tournier H
Acta Radiol Suppl; 1997; 412():69-72. PubMed ID: 9240083
[TBL] [Abstract][Full Text] [Related]
8. Investigation of mechanisms influencing the accumulation of ultrasmall superparamagnetic iron oxide particles in lymph nodes.
Mühler A; Zhang X; Wang H; Lawaczeck R; Weinmann HJ
Invest Radiol; 1995 Feb; 30(2):98-103. PubMed ID: 7540165
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications. A review.
Bonnemain B
J Drug Target; 1998; 6(3):167-74. PubMed ID: 9888302
[TBL] [Abstract][Full Text] [Related]
10. Superparamagnetic iron oxide: pharmacokinetics and toxicity.
Weissleder R; Stark DD; Engelstad BL; Bacon BR; Compton CC; White DL; Jacobs P; Lewis J
AJR Am J Roentgenol; 1989 Jan; 152(1):167-73. PubMed ID: 2783272
[TBL] [Abstract][Full Text] [Related]
11. Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging.
Gellissen J; Axmann Ch; Prescher A; Bohndorf K; Lodemann KP
Magn Reson Imaging; 1999 May; 17(4):557-67. PubMed ID: 10231182
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
[TBL] [Abstract][Full Text] [Related]
13. Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI).
Bordat C; Sich M; Réty F; Bouet O; Cournot G; Cuénod CA; Clément O
J Magn Reson Imaging; 2000 Sep; 12(3):505-9. PubMed ID: 10992320
[TBL] [Abstract][Full Text] [Related]
14. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour.
Lind K; Kresse M; Debus NP; Müller RH
J Drug Target; 2002 May; 10(3):221-30. PubMed ID: 12075823
[TBL] [Abstract][Full Text] [Related]
15. Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model.
Turetschek K; Roberts TP; Floyd E; Preda A; Novikov V; Shames DM; Carter WO; Brasch RC
J Magn Reson Imaging; 2001 Jun; 13(6):882-8. PubMed ID: 11382948
[TBL] [Abstract][Full Text] [Related]
16. Receptor imaging: application to MR imaging of liver cancer.
Reimer P; Weissleder R; Lee AS; Wittenberg J; Brady TJ
Radiology; 1990 Dec; 177(3):729-34. PubMed ID: 2243978
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopy study of intrahepatic ultrasmall superparamagnetic iron oxide kinetics in the rat. Relation with magnetic resonance imaging.
Dupas B; Berreur M; Rohanizadeh R; Bonnemain B; Meflah K; Pradal G
Biol Cell; 1999 Jun; 91(3):195-208. PubMed ID: 10425706
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat.
Majumdar S; Zoghbi SS; Gore JC
Invest Radiol; 1990 Jul; 25(7):771-7. PubMed ID: 2391194
[TBL] [Abstract][Full Text] [Related]
19. Localization of P-31 MR signal with use of superparamagnetic iron oxide particles.
Engelstad BL; White DL; Moseley ME; Stark DD
Radiology; 1990 Aug; 176(2):467-72. PubMed ID: 2367662
[TBL] [Abstract][Full Text] [Related]
20. Oral superparamagnetic particles for magnetic resonance imaging. Effect in plain and viscous aqueous suspensions.
Lönnemark M; Hemmingsson A; Ericsson A; Gundersen HG; Bach-Gansmo T
Acta Radiol; 1990 May; 31(3):303-7. PubMed ID: 2386643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
